4th Quarter - Termination

BAKER & HOSTETLER LLP for ADVAXIS, INC.

Firm
Client
Income
$80,000
Expenses
—
Terminated
Dec 31, 2017

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act, specifically Section 902 related to the Breakthrough Therapy Designation for pharmaceuticals. Policy issues related to Public Law 114-221, the 21st Century Cures Act.

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —
TYLER THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.